US 7615220
High affinity human antibodies to human IL-18 receptor
granted A61PA61P1/00A61P19/02
Quick answer
US patent 7615220 (High affinity human antibodies to human IL-18 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P1/00, A61P19/02, A61P25/00, A61P29/00